vs

Side-by-side financial comparison of LINDBLAD EXPEDITIONS HOLDINGS, INC. (LIND) and Sotera Health Co (SHC). Click either name above to swap in a different company.

Sotera Health Co is the larger business by last-quarter revenue ($303.4M vs $183.2M, roughly 1.7× LINDBLAD EXPEDITIONS HOLDINGS, INC.). Sotera Health Co runs the higher net margin — 11.5% vs -12.9%, a 24.3% gap on every dollar of revenue. On growth, LINDBLAD EXPEDITIONS HOLDINGS, INC. posted the faster year-over-year revenue change (23.3% vs 4.6%). Sotera Health Co produced more free cash flow last quarter ($52.4M vs $3.5M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs 9.2%).

Lindblad Expeditions is an expedition travel company headquartered in New York, NY. The company currently offers expedition cruises to destinations on all seven continents aboard 15 ships with capacities ranging from 28 to 150 guests.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

LIND vs SHC — Head-to-Head

Bigger by revenue
SHC
SHC
1.7× larger
SHC
$303.4M
$183.2M
LIND
Growing faster (revenue YoY)
LIND
LIND
+18.7% gap
LIND
23.3%
4.6%
SHC
Higher net margin
SHC
SHC
24.3% more per $
SHC
11.5%
-12.9%
LIND
More free cash flow
SHC
SHC
$48.9M more FCF
SHC
$52.4M
$3.5M
LIND
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
9.2%
LIND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LIND
LIND
SHC
SHC
Revenue
$183.2M
$303.4M
Net Profit
$-23.6M
$34.8M
Gross Margin
40.3%
54.7%
Operating Margin
-3.0%
23.2%
Net Margin
-12.9%
11.5%
Revenue YoY
23.3%
4.6%
Net Profit YoY
6.0%
182.8%
EPS (diluted)
$-0.45
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LIND
LIND
SHC
SHC
Q4 25
$183.2M
$303.4M
Q3 25
$240.2M
$311.3M
Q2 25
$167.9M
$294.3M
Q1 25
$179.7M
$254.5M
Q4 24
$148.6M
$290.2M
Q3 24
$206.0M
$285.5M
Q2 24
$136.5M
$276.6M
Q1 24
$153.6M
$248.2M
Net Profit
LIND
LIND
SHC
SHC
Q4 25
$-23.6M
$34.8M
Q3 25
$1.2M
$48.4M
Q2 25
$-8.5M
$8.0M
Q1 25
$1.2M
$-13.3M
Q4 24
$-25.0M
$12.3M
Q3 24
$22.5M
$17.0M
Q2 24
$-24.7M
$8.8M
Q1 24
$-4.0M
$6.3M
Gross Margin
LIND
LIND
SHC
SHC
Q4 25
40.3%
54.7%
Q3 25
48.2%
57.0%
Q2 25
45.6%
56.6%
Q1 25
48.3%
53.2%
Q4 24
42.5%
56.6%
Q3 24
46.7%
55.4%
Q2 24
39.2%
55.2%
Q1 24
45.0%
51.2%
Operating Margin
LIND
LIND
SHC
SHC
Q4 25
-3.0%
23.2%
Q3 25
15.0%
23.4%
Q2 25
2.6%
6.4%
Q1 25
5.9%
-5.8%
Q4 24
-5.1%
30.0%
Q3 24
14.3%
28.2%
Q2 24
-6.0%
27.8%
Q1 24
5.1%
21.4%
Net Margin
LIND
LIND
SHC
SHC
Q4 25
-12.9%
11.5%
Q3 25
0.5%
15.5%
Q2 25
-5.1%
2.7%
Q1 25
0.6%
-5.2%
Q4 24
-16.9%
4.2%
Q3 24
10.9%
6.0%
Q2 24
-18.1%
3.2%
Q1 24
-2.6%
2.5%
EPS (diluted)
LIND
LIND
SHC
SHC
Q4 25
$-0.45
$0.12
Q3 25
$0.00
$0.17
Q2 25
$-0.18
$0.03
Q1 25
$0.00
$-0.05
Q4 24
$-0.45
$0.05
Q3 24
$0.36
$0.06
Q2 24
$-0.48
$0.03
Q1 24
$-0.10
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LIND
LIND
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$256.7M
$344.6M
Total DebtLower is stronger
$662.7M
$2.1B
Stockholders' EquityBook value
$-284.5M
$606.0M
Total Assets
$980.0M
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LIND
LIND
SHC
SHC
Q4 25
$256.7M
$344.6M
Q3 25
$261.8M
$299.2M
Q2 25
$200.9M
$332.4M
Q1 25
$188.9M
$304.4M
Q4 24
$183.9M
$277.2M
Q3 24
$193.9M
$306.7M
Q2 24
$168.1M
$246.1M
Q1 24
$177.7M
$261.1M
Total Debt
LIND
LIND
SHC
SHC
Q4 25
$662.7M
$2.1B
Q3 25
$663.5M
$2.1B
Q2 25
$627.3M
$2.2B
Q1 25
$626.4M
$2.2B
Q4 24
$625.5M
$2.2B
Q3 24
$624.5M
$2.2B
Q2 24
$623.6M
$2.2B
Q1 24
$622.7M
$2.2B
Stockholders' Equity
LIND
LIND
SHC
SHC
Q4 25
$-284.5M
$606.0M
Q3 25
$-256.6M
$550.5M
Q2 25
$-263.8M
$511.3M
Q1 25
$-252.2M
$414.1M
Q4 24
$-253.1M
$404.9M
Q3 24
$-226.9M
$470.2M
Q2 24
$-255.5M
$422.8M
Q1 24
$-227.4M
$429.4M
Total Assets
LIND
LIND
SHC
SHC
Q4 25
$980.0M
$3.3B
Q3 25
$976.5M
$3.2B
Q2 25
$936.5M
$3.2B
Q1 25
$908.8M
$3.1B
Q4 24
$876.9M
$3.1B
Q3 24
$889.8M
$3.1B
Q2 24
$858.3M
$3.1B
Q1 24
$868.0M
$3.1B
Debt / Equity
LIND
LIND
SHC
SHC
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LIND
LIND
SHC
SHC
Operating Cash FlowLast quarter
$14.4M
$103.1M
Free Cash FlowOCF − Capex
$3.5M
$52.4M
FCF MarginFCF / Revenue
1.9%
17.3%
Capex IntensityCapex / Revenue
6.0%
16.7%
Cash ConversionOCF / Net Profit
2.96×
TTM Free Cash FlowTrailing 4 quarters
$63.8M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LIND
LIND
SHC
SHC
Q4 25
$14.4M
$103.1M
Q3 25
$19.5M
$71.2M
Q2 25
$29.2M
$57.4M
Q1 25
$48.4M
$55.5M
Q4 24
$1.7M
$55.7M
Q3 24
$28.1M
$97.5M
Q2 24
$18.6M
$61.3M
Q1 24
$43.9M
$9.7M
Free Cash Flow
LIND
LIND
SHC
SHC
Q4 25
$3.5M
$52.4M
Q3 25
$11.9M
$35.0M
Q2 25
$13.5M
$26.2M
Q1 25
$35.0M
$35.6M
Q4 24
$-8.2M
$-10.2M
Q3 24
$18.4M
$61.1M
Q2 24
$11.2M
$19.4M
Q1 24
$37.4M
$-25.2M
FCF Margin
LIND
LIND
SHC
SHC
Q4 25
1.9%
17.3%
Q3 25
5.0%
11.2%
Q2 25
8.0%
8.9%
Q1 25
19.5%
14.0%
Q4 24
-5.5%
-3.5%
Q3 24
8.9%
21.4%
Q2 24
8.2%
7.0%
Q1 24
24.4%
-10.2%
Capex Intensity
LIND
LIND
SHC
SHC
Q4 25
6.0%
16.7%
Q3 25
3.2%
11.6%
Q2 25
9.4%
10.6%
Q1 25
7.5%
7.8%
Q4 24
6.6%
22.7%
Q3 24
4.7%
12.7%
Q2 24
5.4%
15.2%
Q1 24
4.2%
14.1%
Cash Conversion
LIND
LIND
SHC
SHC
Q4 25
2.96×
Q3 25
16.41×
1.47×
Q2 25
7.21×
Q1 25
41.69×
Q4 24
4.52×
Q3 24
1.25×
5.73×
Q2 24
7.00×
Q1 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LIND
LIND

Guest Ticket$96.5M53%
Landexperience$67.3M37%
Other Tour$19.4M11%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons